NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted two new patents by the U.S. Patent and Trademark Office that will complement and strengthen existing proprietary labeling products for the genomics and diagnostics markets.
